Skip to main content

Vericel Corp

VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000887359

In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 7 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.

Superinvestors holding VCEL, Q2 2026

See all superinvestors

No superinvestor reported holding VCEL in Q2 2026.